Shining on Major News: Leading Brands Inc. (NASDAQ:LBIX), Spark Therapeutics, Inc. (NASDAQ:ONCE), Donaldson (NYSE:DCI), Ultragenyx Pharmaceutical (NASDAQ:RARE), Coast Distribution System (NYSEMKT:CRV)

Leading Brands Inc. (NASDAQ:LBIX) belongs to Consumer Goods sector. Its net profit margin is 1.90% and weekly performance is -8.53%. On last trading day company shares ended up $3.43. Leading Brands Inc. (NASDAQ:LBIX) distance from 50-day simple moving average (SMA50) is -8.21%. On 10 July, Leading Brands Inc. (NASDAQ:LBIX) reported Q1 2015 net loss was $(411,000) or $(0.15) per share ($0.15 fully diluted) versus net income of $179,000 or $0.06 per share, basic and fully diluted, in the same quarter of fiscal 2014. Q1 2015 net loss before stock based compensation (“SBC”) was $(411,000) or $(0.15) per share ($0.15 fully diluted) versus net income before SBC of $187,000 or $0.06 per share (0.06 fully diluted) in the same quarter of last year.

Spark Therapeutics, Inc. (NASDAQ:ONCE) shares decreased -0.05% in last trading session and ended the day at $60.96. ONCE return on assets is -28.30%. Spark Therapeutics, Inc. (NASDAQ:ONCE) quarterly performance is -19.38%. Zacks upgraded shares of Spark Therapeutics (NASDAQ:ONCE) from a sell rating to a hold rating in a research note issued to investors on Monday, Market Beat.com reports.

On 14 July, Donaldson Company, Inc. (NYSE:DCI) shares increased 0.56% and was closed at $34.11. DCI EPS growth in last 5 year was 16.20%. Donaldson Company, Inc. (NYSE:DCI) year to date (YTD) performance is -10.89%. Donaldson Company, Inc. (NYSE:DCI) announced that it has entered into a binding agreement to acquire 100 percent of the shares of Industrias Partmo S.A. Partmo is a leading manufacturer of replacement air, lube and fuel filters in Colombia.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) ended the last trading day at $126.77. Company weekly volatility is calculated as 6.17% and price to cash ratio as 13.29. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) showed a weekly performance of 21.45%. Ultragenyx Pharma (NASDAQ: RARE) announced that it has commenced an underwritten public offering of up to $250,000,000 of shares of its common stock. In addition, the company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $37,500,000 of shares of common stock at the public offering price, less the underwriting discount.

Coast Distribution System Inc. (NYSEMKT:CRV) shares remains unchanged in last trading session and ended the day at $5.45. CRV Gross Margin is 17.70% and its return on assets is -0.60%. Coast Distribution System Inc. (NYSEMKT:CRV) quarterly performance is 62.20%. The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of The Coast Distribution System, Inc. (NYSE MKT: CRV) relating to the proposed buyout of the Company by LKQ Corporation in a transaction valued at approximately $29 million.

Leave a Reply

Your email address will not be published. Required fields are marked *